Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -31.846% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCC(=O)c1ccc(OCC(=O)OCC(=O)N2c3ccccc3CC2C)cc1
b CCCNS(=O)(=O)c1cccc(C(=O)NC2CCCc3ccccc32)c1
c CC1CCCC(C)N1/N=C/c1ccccc1Br
Answer: b. CCCNS(=O)(=O)c1cccc(C(=O)NC2CCCc3ccccc32)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNS(=O)(=O)c1cccc(C(=O)NC2CCCc3ccccc32)c1
CCCNS(=O)(=O)c1cccc(C(=O)NC2CCCc3ccccc32)c1
3-(propylsulfamoyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide